Infectious Disease

Top Story

UK site will produce billions of genetically modified mosquitoes

UK site will produce billions of genetically modified mosquitoes
September 23, 2017

A British company plans to build a centralized facility with the capacity to produce one billion genetically modified mosquito eggs every week.

Oxitec said the plant in Oxfordshire, England, will support what it characterized as an increasing global demand for its “Friendly” mosquitoes. The nonbiting male mosquitoes have been genetically modified to pass on a self-limiting gene to their offspring so that they do not survive to maturity, reducing wild populations of Aedes aegypti mosquitoes, which spread diseases like chikungunya, dengue, yellow fever and Zika.

In the Journals Plus

Viral hepatitis causes more deaths than HIV, malaria, TB

September 22, 2017
Despite recent advances in hepatitis C treatment and the availability of hepatitis vaccinations, deaths attributable to viral hepatitis have exceeded those caused by all…

Hepatitis A increase in NYC linked to travel among MSM

September 22, 2017
According to the CDC, the New York City Department of Health and Mental Hygiene reported an increase in hepatitis A infection among men who have sex with men in the city…
In the Journals Plus

Routine rapid HCV testing cost-effective in younger generations

September 22, 2017
Routine rapid testing for hepatitis C virus infection among adolescents and young adults was cost-effective when implemented in communities with a high prevalence of the…

Gurman says, ‘Our voice is their voice’ in explaining the importance of physician advocacy

September 22, 2017
At a time when the state of health care is in flux, it is critical that physicians engage in the national debate by telling their stories and those of their patients to…
More Headlines »
CME CNE CPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
More »

Major physician groups urge Senate to stabilize health insurance markets

September 21, 2017
A coalition of major physician groups submitted a testimony to the Senate Health, Education, Labor and Pensions…
More »
Resource Centers
ASM Microbe

ASM Microbe

Video
Meeting News

VIDEO: HCV elimination requires equitable care for injection drug users

April 19, 2017
More »
Advertisement
Advertisement